강세병 (울산과학기술원)님의 논문 목록 | 한빛사논문 > 한빛사

강세병 님의 논문 목록

울산과학기술원

CV File 1 MB

Compact clustering of highly oligomerized anti-DR5 nanobodies effectively drives apoptotic cancer cell death, significantly suppressing tumor growth
- Nano Today, Available online 11 June 2025 | https://doi.org/10.1016/j.nantod.2025.102834
- 2025-06
- 바이오·의료융합
- 한빛사논문
Effective in vivo delivery of diphtheria toxin using protein cage nanoparticles for targeted cancer therapy
- Acta Biomater., Jul 03 2025, S1742-7061(25)00482-9 | https://doi.org/10.1016/j.actbio.2025.07.005
- 2025-07
- 바이오·의료융합
- 한빛사논문
In situ forming and self-crosslinkable protein hydrogels for localized cancer therapy and topical wound healing
- J. Control. Release, Dec 17 2024, S0168-3659(24)00877-0 | https://doi.org/10.1016/j.jconrel.2024.12.026
- 2024-12
- 바이오·의료융합
- 한빛사논문
CD13-targeting and TRAIL-displaying protein nanoparticles effectively induce apoptotic cell death of acute myeloid leukemia, prolonging survival in mouse models
- Nano Today, Available online 4 September 2024 | https://doi.org/10.1016/j.nantod.2024.102474
- 2024-09
- 생명과학
- 한빛사논문
Protein cage nanoparticle-based NK cell-engaging nanodrones (NKeNDs) effectively recruit NK cells to target tumor sites and suppress tumor growth
- Nano Today, Available online 2 December 2023 | https://doi.org/10.1016/j.nantod.2023.102075
- 2023-12
- 생명과학
- 한빛사논문
Lactate oxidase/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth
- J. Nanobiotechnol., 2023 Jan 3;21(1):5 | https://doi.org/10.1186/s12951-022-01762-6
- 2023-01
- 바이오·의료융합
- 한빛사논문
TRAIL & EGFR affibody dual-display on a protein nanoparticle synergistically suppresses tumor growth
- J. Control. Release, Volume 349, September 2022, Pages 367-378 | https://doi.org/10.1016/j.jconrel.2022.07.004
- 2022-09
- 생명과학
- 한빛사논문
Directing ricin-based immunotoxins with targeting affibodies and KDEL signal peptide to cancer cells effectively induces apoptosis and tumor suppression
- J. Nanobiotechnol., Published: 23 August 2022;20(1):387 | doi: 10.1186/s12951-022-01601-8
- 2022-08
- 바이오·의료융합
- 한빛사논문
Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T1 contrast agents for high-field MRI
- J. Control. Release, Volume 335, 10 July 2021, Pages 269-280 | https://doi.org/10.1016/j.jconrel.2021.05.029
- 2021-07
- 바이오·의료융합
- 한빛사논문
Cloaking nanoparticles with protein corona shield for targeted drug delivery
- Nat. Commun., Published 31 October 2018, 9, Article number: 4548 | https://doi.org/10.1038/s41467-018-06979-4
- 2018-10
- 바이오·의료융합
- 한빛사논문, 상위피인용논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기